Related Experiment Video
Updated: Jan 3, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Approach to Patients with Stinging Insect Allergy
Elissa M Abrams1, David B K Golden2
1Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, FE125-685 William Avenue, Winnipeg, Manitoba R2A 5L9, Canada.
Stinging insect allergy can be fatal. Diagnosis involves allergy testing, and anaphylaxis requires immediate epinephrine treatment. Venom immunotherapy offers highly effective long-term management for allergic reactions.
Area of Science:
- Allergy and Immunology
- Toxicology
Background:
- Stinging insect allergy, though uncommon, poses a significant risk of life-threatening reactions.
- Accurate diagnosis is crucial for effective management and patient safety.
Purpose of the Study:
- To outline the diagnostic and management strategies for stinging insect allergy.
- To highlight the efficacy of venom immunotherapy in preventing future anaphylactic events.
Main Methods:
- Clinical history assessment
- Diagnostic skin or blood testing by an allergist
- Risk stratification using baseline serum tryptase levels
Main Results:
- Anaphylaxis treatment involves epinephrine, supportive care, and adjunct measures.
- Venom immunotherapy demonstrates high effectiveness in long-term management.
- Venom immunotherapy reduces the risk of sting anaphylaxis by up to 98%.
Conclusions:
- Prompt diagnosis and appropriate treatment are essential for managing stinging insect allergy.
- Venom immunotherapy is a highly effective preventative measure for patients with a history of anaphylaxis.
- Maintenance therapy for venom immunotherapy can often be discontinued after five years.
More Related Videos
Related Concept Videos
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Asthma-I: Introduction

